Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Zeteletinib (BOS-172738; DS-5010) is a highly potent and selective orally active inhibitor of the RET kinase. It demonstrates nanomolar potency against RET while exhibiting over 300-fold selectivity against VEGFR2. Zeteletinib exhibits remarkable efficacy against the wild-type RET, RET V804M/L gatekeeper mutants, as well as the frequently occurring oncogenic RET mutation M918T. Its antitumor activity is potent.
Description | Zeteletinib (BOS-172738; DS-5010) is a highly potent and selective orally active inhibitor of the RET kinase. It demonstrates nanomolar potency against RET while exhibiting over 300-fold selectivity against VEGFR2. Zeteletinib exhibits remarkable efficacy against the wild-type RET, RET V804M/L gatekeeper mutants, as well as the frequently occurring oncogenic RET mutation M918T. Its antitumor activity is potent. |
In vitro | In biochemical assays involving 106 kinases, Zeteletinib (BOS-172738; DS-5010) achieved more than 80% inhibition of RET and platelet-derived growth factor receptor (PDGFR) alpha/beta at a concentration of 193 nM. Zeteletinib displayed potent activity against RET and RET-GKm (V804L) with IC50 values in the single-digit nanomolar range, even in the presence of high ATP concentrations. Conversely, its inhibitory effect on KDR exceeded 1000 nM[1]. |
In vivo | In a Ba/F3-RET subcutaneous tumor model, Zeteletinib (BOS-172738; DS-5010) administered at 10 mg/kg twice daily (bid) effectively induces tumor regression[1]. Similarly, in an LC2/ad NSCLC xenograft model harboring the RET-CCDC6 fusion gene, a dosage regimen of Zeteletinib at 1 mg/kg three times daily (tid) has been shown to induce tumor regression[1]. |
Synonyms | BOS-172738, DS-5010, Zeteletinib |
Molecular Weight | 500.478 |
Formula | C25H23F3N4O4 |
CAS No. | 2216753-97-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Zeteletinib 2216753-97-6 BOS172738 DS5010 BOS-172738 DS 5010 DS-5010 BOS 172738 inhibitor inhibit